The incidence of Milk Thistle material that contains little or no silymarin (the active constituents) is ‘relatively high’ and represents an ‘ongoing problem’, according to a new bulletin from the ABC-AHP-NCNPR Botanical Adulterants Prevention Program...
“We cannot enforce against what we cannot see or cannot know is there”, said FDA’s Steven Tave, and that’s why mandatory listing requirement for dietary supplement products would be a step forward for enforcement.
As sales of dietary supplements and natural products remain high – and many companies report record sales – the strain on the supply chain is immense, and for botanicals in particular, and that means a difficult 2021 could be on the horizon.
An Arizona-based algae company is building on work done by a predecessor to bring an EPA-rich supplement ingredient to market. The company says an additional facility that will bring it to commercial scale will be completed by the end of this year.
Has Covid-19 affected your business (positively and/or negatively)? Are you changing how you think about the supply chain? And which health categories are the big winners and losers in 2020?
GW Pharmaceuticals and supplement retailer GNC have reportedly been among the companies meeting recently with a White House division to discuss aspects of CBD regulation.
It was hard enough keeping everyone on the same compliance page and then along came COVID-19. During the pandemic, FDA has published dozens of guidance documents for the dietary supplement industry as well as other stakeholders.
Nutraveris, a software firm that consults on regulatory affairs for nutrition and dietary supplement markets in Europe, has announced that they have launched an online platform for supplement compliance in the United States.
A new paper from a prominent industry critic has found a number of unapproved drugs in a suite of cognitive and memory support products purchased online.
Testing done by supplement manufacturer Nature’s Way and publicized by the American Botanical Council further solidifies the notion that adulteration of elderberry products is on the rise.
A ‘Regulatory Gap’ exists within the US dietary supplements industry, and recent talk of modernizing the regulations are ways to close that gap, FDA’s Steven Tave said yesterday
The recent upheavals in the United States around race relations has the nation questioning the insidious role prejudice has played in many walks of life. One group is seeking to use that rekindled awareness as added leverage to ensure equal opportunity...
Dietary supplement manufacturer Pharmavite has filed a RICO lawsuit against the Clean Label Project, alleging that the organization’s testing and product grading activities amount to a protection racket.
A nonprofit group has asked FDA to crack down on the sale of tianeptine, an ingredient that is sold as an antidepressant drug in many markets outside of the United States.
